We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$166B
AUM Growth
+$11.6B
Cap. Flow
-$367M
Cap. Flow %
-0.22%
Top 10 Hldgs %
20.23%
Holding
6,654
New
397
Increased
2,681
Reduced
2,205
Closed
444

Sector Composition

Rank Sector Weight
1 Technology 12.22%
2 Financials 7.52%
3 Healthcare 6.46%
4 Consumer Discretionary 6.41%
5 Communication Services 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROO icon
5076
TROOPS Inc
TROO
$215M
$23K ﹤0.01%
9,353
-4,350
-32% -$8.26K
UFPT icon
5077
UFP Technologies
UFPT
$1.96B
$23K ﹤0.01%
409
-125
-23% -$6.79K
WIP icon
5078
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$466M
$23K ﹤0.01%
413
VIRX
5079
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$23K ﹤0.01%
2,007
-31,587
-94% -$317K
CSSE
5080
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$23K ﹤0.01%
+547
New +$19.2K
GMDA
5081
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$23K ﹤0.01%
3,589
+2,458
+217% +$16.9K
CSPR
5082
DELISTED
Casper Sleep Inc.
CSPR
$23K ﹤0.01%
2,766
+708
+34% +$6.18K
DCRBU
5083
DELISTED
Decarbonization Plus Acquisition Corporation Unit
DCRBU
$23K ﹤0.01%
2,033
AUTL
5084
Autolus Therapeutics
AUTL
$381M
$22K ﹤0.01%
3,271
+2,620
+402% +$16.3K
AXDX
5085
DELISTED
Accelerate Diagnostics
AXDX
$22K ﹤0.01%
267
-33
-11% -$2.62K
CECO icon
5086
Ceco Environmental
CECO
$3.75B
$22K ﹤0.01%
3,049
+339
+13% +$2.62K
CGEM icon
5087
Cullinan Oncology
CGEM
$1.07B
$22K ﹤0.01%
867
-1,603
-65% -$49.3K
CSM icon
5088
ProShares Large Cap Core Plus
CSM
$511M
$22K ﹤0.01%
450
DFAC icon
5089
Dimensional US Core Equity 2 ETF
DFAC
$47.4B
$22K ﹤0.01%
+801
New +$21.3K
DSGR icon
5090
Distribution Solutions Group
DSGR
$1.6B
$22K ﹤0.01%
840
+254
+43% +$7.01K
ESPO icon
5091
VanEck Video Gaming and eSports ETF
ESPO
$250M
$22K ﹤0.01%
310
FRST icon
5092
Primis Financial Corp
FRST
$398M
$22K ﹤0.01%
1,468
-217
-13% -$3.26K
IGEB icon
5093
iShares Investment Grade Systematic Bond ETF
IGEB
$1.45B
$22K ﹤0.01%
400
LABU icon
5094
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$526M
$22K ﹤0.01%
15
MYPS icon
5095
PLAYSTUDIOS Inc
MYPS
$74M
$22K ﹤0.01%
+3,000
New +$29K
NXG
5096
NXG NextGen Infrastructure Income Fund
NXG
$312M
$22K ﹤0.01%
457
+237
+108% +$10.8K
IMDX
5097
Insight Molecular Diagnostics
IMDX
$147M
$22K ﹤0.01%
194
-42
-18% -$4.1K
OOMA icon
5098
Ooma
OOMA
$588M
$22K ﹤0.01%
1,152
-371
-24% -$6.72K
OPY icon
5099
Oppenheimer Holdings
OPY
$1.17B
$22K ﹤0.01%
449
-176
-28% -$8.49K
PBP icon
5100
Invesco S&P 500 BuyWrite ETF
PBP
$351M
$22K ﹤0.01%
+969
New +$21.3K

Similar funds

Citigroup's Q2 2021 Portfolio in Review

As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
  • Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
  • Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
  • Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
  • Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
  • Citigroup opened 397 new positions and closed 444 in Q2 2021.
  • Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.

Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.